Synmedic Laboratories Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Synmedic Laboratories Pharmaceutical Export Portfolio Dataset — 2 Products, $323.1K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Synmedic Laboratories — Pharmaceutical Exporter Profile (2026) | 2 Products, $323.1K Trade | TransData Nexus

Synmedic Laboratories

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $323.1K Total Trade · DGFT Verified

Synmedic Laboratories is an Indian pharmaceutical exporter with a total trade value of $323.1K across 2 products in 2 therapeutic categories. Based on 10 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Sulfasalazine ($258.7K), Alprazolam ($64.4K), .

Synmedic Laboratories — Export Portfolio & Destination Treemap

Synmedic Laboratories pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Synmedic Laboratories? — Company Overview & Market Position

Synmedic Laboratories Private Limited, established on September 18, 2009, is a privately held pharmaceutical company headquartered in New Delhi, India. The company is registered under the Corporate Identification Number (CIN) U24232DL2009PTC194500. Synmedic specializes in the manufacture and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. In 2013, Synmedic became part of the Dhanuka Group of Companies, a diversified conglomerate, which has provided additional resources and professional management to enhance its operations.

The company's authorized capital is ₹0.10 million, with a paid-up capital of ₹0.10 million. As of the latest available data, Synmedic Laboratories employs between 51 to 200 individuals. The company's registered office is located at 82, Abhinash Mansion, 1st Floor, Joshi Road, Karol Bagh, New Delhi, Delhi 110005, India.

What Does Synmedic Laboratories Export? — Product Portfolio Analysis

Top Products by Export Value

1Sulfasalazine$258.7K 2

Product Portfolio — Top 2 by Export Value

Synmedic Laboratories exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Sulfasalazine	Gastrointestinal	$258.7K	7	8.0%	4
2	Alprazolam	CNS & Psychiatric	$64.4K	3	0.4%	12

Synmedic Laboratories exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $323.1K. The top category is Gastrointestinal (80.1% of portfolio), followed by CNS & Psychiatric (19.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Synmedic Laboratories — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Synmedic Laboratories operates a state-of-the-art manufacturing facility in Faridabad, Haryana, India. The plant is equipped with sophisticated instruments, including U.V. Spectrophotometer, H.P.L.C, G.C., and F.T.I.R. Spectrophotometer, to ensure high-quality production standards. The facility adheres to current Good Manufacturing Practices (cGMP) norms, with continuous efforts to improve manufacturing systems and Standard Operating Procedures for better Quality Assurance.

3Key Leadership

The leadership team at Synmedic Laboratories includes Directors Harsh Dhanuka and Manish Dhanuka, who have been associated with the company since 2015. The company's management comprises qualified professionals in manufacturing, quality control, quality assurance, marketing, research, and development, ensuring a comprehensive approach to pharmaceutical production and export.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Synmedic Laboratories Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Synmedic Laboratories has established a presence in various regulated markets, including Southeast Asia, Africa, the Commonwealth of Independent States (CIS), and South America. The company's manufacturing facility has been audited and approved by regulatory authorities from these regions, facilitating market access. Synmedic's regulatory affairs team has obtained over a hundred product registrations globally, demonstrating its commitment to meeting international standards.

2Emerging Markets

Synmedic Laboratories has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's adherence to international regulatory standards, including obtaining approvals from various countries, has enabled it to penetrate these markets effectively. Synmedic's commitment to quality and regulatory compliance has facilitated its growth in these regions.

3Geographic Strategy

Synmedic Laboratories' export portfolio is concentrated in two therapeutic categories: Gastrointestinal (80.1%) and CNS & Psychiatric (19.9%). The company's top five products—Sulfasalazine and Alprazolam—account for 100% of its export value, indicating a high level of portfolio concentration. This focus on a limited number of products and therapeutic areas may expose the company to risks associated with market fluctuations and regulatory changes in these segments.

Synmedic Laboratories — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Synmedic Laboratories has not publicly disclosed specific details regarding its FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history. The company's regulatory affairs team has obtained over a hundred product registrations globally, indicating a proactive approach to meeting international standards.

2WHO & EU GMP

Synmedic Laboratories has not publicly disclosed specific details regarding its World Health Organization (WHO) prequalification status or European Union Good Manufacturing Practice (EU GMP) certifications. The company's manufacturing facility has been audited and approved by various regulatory authorities from Southeast Asia, Africa, the Commonwealth of Independent States (CIS), and South America, facilitating market access in these regions.

3CDSCO & Indian Regulatory

Synmedic Laboratories holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) in India. The company's manufacturing facility has been audited and approved by various regulatory authorities, indicating compliance with Indian regulatory standards. Synmedic's regulatory affairs team has obtained over a hundred product registrations globally, demonstrating its commitment to meeting international standards.

Synmedic Laboratories — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Synmedic Laboratories operates in the pharmaceutical export market, focusing on finished pharmaceutical formulations in the gastrointestinal and CNS & psychiatric therapeutic categories. The company's top competitors in overlapping categories include established pharmaceutical exporters with diversified product portfolios and global market presence. Synmedic's portfolio concentration on a limited number of products and therapeutic areas may impact its competitive positioning in the broader market.

2Key Differentiators

Synmedic Laboratories' key differentiators include its focus on quality manufacturing, adherence to international regulatory standards, and a specialized product portfolio in the gastrointestinal and CNS & psychiatric therapeutic categories. The company's manufacturing facility is equipped with advanced instruments and follows cGMP norms, ensuring high-quality production standards.

3Strategic Position

Synmedic Laboratories' current strategic direction focuses on the manufacture and export of finished pharmaceutical formulations, with a concentration on gastrointestinal and CNS & psychiatric therapeutic categories. The company's portfolio concentration on a limited number of products and therapeutic areas may expose it to risks associated with market fluctuations and regulatory changes in these segments. Future strategic initiatives may involve diversification of the product portfolio and expansion into additional therapeutic areas to mitigate concentration risks.

Buyer Due Diligence Brief — Evaluating Synmedic Laboratories as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Synmedic Laboratories has a track record of obtaining over a hundred product registrations globally, indicating a proactive approach to meeting international standards. The company's manufacturing facility has been audited and approved by various regulatory authorities from Southeast Asia, Africa, the Commonwealth of Independent States (CIS), and South America, facilitating market access in these regions.

2Certifications to Verify

Importers should verify the following certifications when considering Synmedic Laboratories as a supplier:

FDA Facility Registration: Confirm the facility's registration status with the U.S. Food and Drug Administration (FDA).

WHO-GMP Certification: Verify the World Health Organization's Good Manufacturing Practice certification.

EU GMP Certification: Confirm compliance with European Union Good Manufacturing Practice standards.

Frequently Asked Questions — Synmedic Laboratories

How many pharmaceutical products does Synmedic Laboratories export from India?

Synmedic Laboratories exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Sulfasalazine ($258.7K), Alprazolam ($64.4K). Total export value is $323.1K.

What is Synmedic Laboratories's total pharmaceutical export value?

Synmedic Laboratories's total pharmaceutical export value is $323.1K, based on 10 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Synmedic Laboratories cover?

Synmedic Laboratories exports across 2 therapeutic categories. The largest are Gastrointestinal (80.1%, 1 products), CNS & Psychiatric (19.9%, 1 products).

Get Full Synmedic Laboratories Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.